Efficient automated one-step synthesis of 2-[18F]fluoroethylcholine for clinical imaging: Optimized reaction conditions and improved quality controls of different synthetic approaches

Nuclear Medicine and Biology

Volumn 37, Issue 3, 2010, Pages 309-315

  Asti, Mattia ^a   Farioli, Daniela ^a   Iori, Michele ^a   Guidotti, Claudio ^a   Versari, Annibale ^a   Salvo, Diana ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

2 18F fluoroethylcholine; 18FECH; Brain cancer; One step reaction; Prostate cancer

Indexed keywords

1,2 BIS(TOSLOXY)ETHANE; 4,4 DIMETHYLMORPHOLINIUM; CHOLINE DERIVATIVE; FLUORINE 18; FLUOROETHYLCHOLINE F 18; N,N DIMETHYLAMINOETHANOL; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CONDUCTOMETRY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGE ANALYSIS; QUALITY CONTROL; RADIOASSAY; RADIOMETRY; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET RADIATION;

CHOLINE; ISOTOPE LABELING; RADIOPHARMACEUTICALS; ROBOTICS;

EID: 77950299829     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2009.12.009     Document Type: Article

References (21)

1. Katz-Brull R., Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells: NMR application of the zero trans method. Anticancer Res. 1996, 16:1375-1380.
2. Michel V., Yuan Z., Ramsubir S., Bakovic M. Choline transport for phospholipid synthesis. Exp Biol Med 2006, 231:490-504.
3. Haeffner E.W. Studies on choline permeation through the plasma membrane and its incorporation into phosphatidyl choline of Ehrlich-Lettré-ascites tumour cells in vitro. Eur J Biochem 1975, 51:219-228.
4. 11C]choline. J Nucl Med 1997, 38:842-847.
5. Hara T., Kosaka N., Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998, 39:990-995.
6. Kotzerke J., Gschwend J.E., Neumaier B. PET for prostate cancer imaging: still a quandary or the ultimate solution?. J Nucl Med 2002, 43:200-202.
7. Kwee S.A., DeGrado T.R., Talbot J.N., Gutman F., Coel M.N. Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med 2007, 37:420-428.
8. 18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med 2006, 33:1387-1398.
9. Deves R., Krupka R.M. The binding and translocation steps in transport as related to substrate structure: a study of the choline carrier of erythrocytes. Biochim Biophys Acta 1979, 557:469-485.
10. Clary G.L., Tsai C.F., Guynn R.W. Substrate specificity of choline kinase. Arch Biochem Biophys 1987, 254:214-221.
11. 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 2001, 61:110-117.
12. 18F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med. 2001, 43:187-199.
13. Pascali G, D'Antonio L, Bovone P, Gerundivi P, August T. Optimization of automated large-scale production of [18F] fluoroethylcholine for PET prostate cancer imaging. doi:10.1016/j.nucmedbio.2009.01.004.
14. 18F]fluoroethylcholine for prostate cancer imaging. Bioorg Med Chem 2008, 16:9121-9126.
15. 18F]fluoroethane. Tetrahedron Lett 2003, 44:97-99.
16. 18F]fluoroethylcholine as a radiotracer for cancer imaging. Bioorg Med Chem 2007, 15:3171-3175.
17. Wadsak W., Mien L.K., Ettlinger D.E., et al. 18F fluoroethylations: different strategies for the rapid translation of 11C-methylated radiotracers. Nuc Med Biol 2007, 34:1019-1028.
18. 18F]fluoroethylcholine uptake in prostate cancer cells. J Nucl Med 2006, 47(Suppl 1):425P.
19. Iwata R., Pascali C., Bogni A., Furumoto S., Terasaki K., Yanai K. [18F]Fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent: preparation and application to the on-column preparation of [18F]fluorocholine. Appl Radiat Isot 2002, 57:347-352.
20. Kryza D., Tadino V., Filannino M.A., Villeret G., Lemoucheux L. Fully automated [18F]fluorocholine synthesis in the TracerLab MXFDG Coincidence synthesizer. Nucl Med Biol 2008, 35:5-260.
21. 18F] FDG preparations. Nucl Med Biol 1997, 24:193-195.